CD36 inhibition reduces non-small-cell lung cancer development through AKT-mTOR pathway. - Liu, Hui; Guo, Wentong; Wang, Tianxiang; Cao, Peichang; Zou, Tingfeng; Peng, Ying; Yan, Tengteng; Liao, Chenzhong; Li, Qingshan; Duan, Yajun; Han, Jihong; Zhang, Baotong; et al. (Cell Biology & Toxicology, 2024)